First experience with the wearable cardioverter defibrillator in the Netherlands

Netherlands Heart Journal

Volumn 20, Issue 2, 2012, Pages 77-81

  Knops, R E ^a   Kooiman, K M ^a   Ten Sande, J N ^a   de Groot, J R ^a   Wilde, A A M ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Wearable cardiac defibrillator

Indexed keywords

ANTIBIOTIC AGENT;

ADULT; ALARM MONITOR; ARTICLE; AUTOMATED EXTERNAL DEFIBRILLATOR; CASE REPORT; CLINICAL PRACTICE; CONGESTIVE CARDIOMYOPATHY; COST CONTROL; DEFIBRILLATION; DEFIBRILLATOR; DEVICE REMOVAL; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HIGH RISK PATIENT; HUMAN; INFORMATION PROCESSING; MALE; NETHERLANDS; NONSUSTAINED HEART VENTRICLE TACHYCARDIA; OUTCOME ASSESSMENT; OUTPATIENT CARE; PATIENT COMPLIANCE; PATIENT EDUCATION; PATIENT SATISFACTION; SEPSIS; SKIN CONDUCTANCE; STAPHYLOCOCCUS INFECTION; SUDDEN DEATH; SURVIVAL; SYNCOPE; TREATMENT INDICATION; VIRUS MYOCARDITIS; WEARABLE CARDIOVERTER DEFIBRILLATOR;

EID: 84856259745     PISSN: 15685888     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12471-011-0227-9     Document Type: Article

References (12)

1. Moss AJ, Zareba W, Hall WJ, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med. 2002;346:877-83.
2. The Antiarrhythmic Versus Implantable Defibrillators (AVID) Investigators. A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias. N Engl J Med. 1997;337 (22):1576-83.
3. Zipes DP, Borggrefe M, Buxton AE, et al. ACC/AHA/ESC 2006 Guidelines for the prevention of sudden cardiac death. Europace. 2006;8(746):837.
4. Dickstein K, Vardas P, Auricchio A, et al. 2010 Focused update of ESC guidelines on device therapy in heart failure. Eur Heart J. 2010;31:2677-87.
5. Meltendorf U, Wollbrueck A, Auricchio A, et al. The wearable defibrillator - A new method to prevent sudden death. PACE. 2000;23(4 part II):606.
6. Feldman AM, Klein H, Tchou PJ, et al. Use of a wearable defibrillator in terminating tachyarrhythmias in patients at high risk of sudden death: results of the WEARIT/BIROAD. PACE. 2004;27(1):4-9.
7. Zoll Lifecor Cooperation. LifeVest System WCD 3100 Operator's Manual. 2009.
8. Everitt MD, Saarel EV. Use of the wearable defibrillator in children. PACE. 2010;33(6):742-6.
9. Grimm W, Menz V, Hoffmann J, et al. Complications of third-generation implantable cardioverter-defibrillator therapy. PACE. 1999;22(1 part II):206-11.
10. Klein HU, Meltendorf U, Reek S, et al. Bridging a temporary high risk of sudden arrhythmic death. Experience with the wearable cardioverter defibrillator (WCD). PACE. 2010;33:353-67.
11. Mishkin JD, Saxonhouse SJ, Woo GW, et al. Appropriate evaluation and treatment of heart failurepatients after implantable cardioverter-defibrillator discharge: time to go beyond the initial shock. J Am Coll Cardiol. 2009;54(22):1993-2000.
12. Daubert JP, Zareba W, Cannom DS, et al. Inappropriate impantable cardioverter-defibrillator shocks in MADIT II. frequency, mechanisms, predictors, and survival impact. J Am Coll Cardiol. 2008;51 (1):357-65.